Article contents
Psychiatric medicines in India: why public healthcare facilities and a thriving generics industry cannot assure access and affordability
Published online by Cambridge University Press: 02 January 2018
Extract
This commentary highlights the poor availability of essential psychiatric medicines at public sector facilities in India and illustrates why even a flourishing generics industry does not assure access to affordable psychiatric medicines for most Indian patients. The paper outlines the Indian government's pricing regulations and then enumerates recommendations for reform.
- Type
- Thematic papers
- Information
- Creative Commons
- This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits noncommercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
- Copyright
- Copyright © Royal College of Psychiatrists 2012
References
- 1
- Cited by
eLetters
No eLetters have been published for this article.